The 6H1 orphan receptor, claimed to be the p2y5 receptor, does not mediate nucleotide-promoted second messenger responses

被引:39
作者
Li, Q
Schachter, JB
Harden, TK
Nicholas, RA
机构
[1] Department of Pharmacology, CB No. 7365, Univ. of N. Carolina at Chapel Hill, Chapel Hill
关键词
D O I
10.1006/bbrc.1997.6984
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
An orphan G protein-coupled receptor, termed 6H1, with similar to 30% sequence identity to P2Y receptors has been proposed to be a P2Y receptor (p2y5) based solely on a radioligand binding assay with [S-35]dATP alpha S [Webb et al. (1997) Biochem. Biophys. Res. Commun. 219:105-110]. Previous work in our laboratory has shown that [S-35]-dATP alpha S is not a general ligand for P2Y receptors, and thus inclusion of the p2y5 receptor in the family of P2Y receptors is questionable. To define unambiguously whether the p2y5 receptor is a P2Y receptor, we have cloned the turkey homologue of the chick p2y5 receptor. Sequence analysis indicated that the turkey receptor contains an additional 32 amino acids at its carboxy terminus compared to the published chick sequence. HA epitope-tagged turkey p2y5 receptors were stably expressed in 1321N1 human astrocytoma cells, and cells shown to express the HA-tagged p2y5 receptor by an intact cell-based ELISA were used to determine whether changes id second messenger levels occurred in response to a series of nucleotides. ATP, ADP, UTP, UDP, dATP alpha S, and A(2)P(4) had no effect on either inositol phosphate or cyclic AMP concentrations in cells expressing the p2y5 receptor. Robust inositol phosphate and cyclic AMP responses occurred to other G protein-coupled receptors expressed in 1321N1 cells, which indicate that these cells contain all of the necessary signaling components to generate these second messenger responses. These data indicate that the 6H1/p2y5 receptor is not a member of the P2Y receptor family of signaling proteins. (C) 1997 Academic Press.
引用
收藏
页码:455 / 460
页数:6
相关论文
共 34 条
[1]   Molecular cloning of a novel P2 purinoceptor from human erythroleukemia cells [J].
Akbar, GKM ;
Dasari, VR ;
Webb, TE ;
Ayyanathan, K ;
Pillarisetti, K ;
Sandhu, AK ;
Athwal, RS ;
Daniel, JL ;
Ashby, B ;
Barnard, EA ;
Kunapuli, SP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (31) :18363-18367
[2]  
ALI H, 1994, J BIOL CHEM, V269, P24557
[3]  
ALI H, 1993, J BIOL CHEM, V268, P24247
[4]  
[Anonymous], [No title captured]
[5]  
BERRIE CP, 1989, MOL PHARMACOL, V35, P526
[6]  
BOYER JL, 1993, J PHARMACOL EXP THER, V267, P1140
[7]  
BOYER JL, 1989, J BIOL CHEM, V264, P884
[8]  
CHAREST R, 1985, J BIOL CHEM, V260, P5789
[9]  
Comstock K E, 1997, Methods Mol Biol, V62, P207
[10]  
FILTZ TM, 1994, MOL PHARMACOL, V46, P8